NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
CURAPATH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CURAPATH
ST13
US500000097534202Class
5, 40, 42, 45
Filing
97534202
Registration
7779108
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/30/2025
Trademark type
Word
Nice classes
5, 40, 42, 45
Filing date
08/04/2022
Registration date
04/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/14/2022
First use in commerce
10/14/2022
Drawing code
4
Owner type
16
Owner location
San Francisco, CA
Examiner
HOWARD, PARKER
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Polypeptide Therapeutic Solutions USA LLC
Representatives
Julie R. Fenstermaker BENESCH FRIEDLANDER COPLAN & ARONOFF LLP
Technical classification
Nice Classes
Class 5Class 40Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceutical preparationspolyamino acid based therapeuticspolymerlipid based pharmaceutical preparations for the treatment of viralbacterialmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricgenetic and immune system related diseases and disorders
Class 40
Custom manufacture of polyamino acid based and nanoparticle based biopharmaceutical preparations for purposes of scientific and medical research and for therapeutic purposes
Class 42
Consulting services in the fields of biotechnologypharmaceutical research and development of polyamino acid based and nanoparticle molecules for researchdrugvaccinetherapeutic product use; product research and development for use in manufacturing of polyamino acid based and nanoparticle molecules; quality management servicesquality evaluation and analysisquality assurance and quality control in the field of biotechnology and polyamino acid based and nanoparticle molecules
Class 45
Regulatory compliance consulting services in the biotechnology fieldsreviewing standards and practices and assisting third parties with compliance with governmental lawsregulations and rules pertaining to medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/02/2025
IUAF
USE AMENDMENT FILED
01/23/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/23/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/23/2024
EX1G
SOU EXTENSION 1 GRANTED
08/23/2024
EXT1
SOU EXTENSION 1 FILED
08/23/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/23/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2024
PUBO
PUBLISHED FOR OPPOSITION
01/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
08/18/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
08/18/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/25/2023
GNRT
NON-FINAL ACTION E-MAILED
05/25/2023
CNRT
NON-FINAL ACTION WRITTEN
05/25/2023
DOCK
ASSIGNED TO EXAMINER
05/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/25/2022
NWAP
NEW APPLICATION ENTERED
08/08/2022
Continuous trademark protection
Get notified about every new filing that threatens CURAPATH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.